*注:相關(guān)信息一覽
參考文獻(xiàn):
[1] 血清轉(zhuǎn)鐵蛋白受體和血清鐵蛋白在鑒別慢性病貧血和缺鐵性貧血價(jià)值的評(píng)價(jià)
[2]《中國(guó)腫瘤相關(guān)性貧血共識(shí)》解讀
[3] Caro JJ ,Salas M,Ward A , et al. Anemia as an independent prognostic factor for survival in patients with cancer:a systemic, quantitative review[J].Cancer,2001,91(12):2214-2221.
[4] Rogers J, Lacroix L , Durmowitz G, et al.The role of cytokines in the regulation of ferritin expression[J]. Adv ExpMed Biol,1994,356(2):127‐132.
[5] 賈國(guó)存,劉玉峰.富鐵對(duì)HL‐60 細(xì)胞增殖及化療藥物誘導(dǎo)其凋亡的影響[J].中華血液學(xué)雜志,2001,22(7):381-382.
Haq RU , Wererly JP, Chitambar CR.Induction of apoptosis by iron deprivation in human leukemic CCRF‐CEMcells[J]. Exp Hematol,1995,23(5):428-432.
[6] 鄧念英,陳海燕,羅培英,等.蛋白琥珀酸鐵治療妊娠期貧血療效觀察[J].中國(guó)藥師,2015,18(9):1546-1547.
[7] 劉 靜,尚 煜,王建梅,等.鐵蛋白篩查對(duì)早期識(shí)別孕婦貧血的應(yīng)用價(jià)值[J].現(xiàn)代中西醫(yī)結(jié)合雜志,2014,23(2):143-144.
本文經(jīng)由羅氏醫(yī)學(xué)部審核后發(fā)布